Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Limiting CDR-H3 diversity abrogates the antibody response to the bacterial polysaccharide a 1?3 dextran.

Limiting CDR-H3 diversity abrogates the antibody response to the bacterial polysaccharide a 1?3 dextran. J Immunol. 2011 Jul 15; 187(2):879-86.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.